Evidence-informed integrative therapies offered alongside conventional medicine — expanding options for patients seeking holistic, personalised care.
Prof. Dr. Behera integrates selected evidence-based alternative therapies into patient care — offering ozone therapy, chelation, and high-dose intravenous vitamin C as complementary options for appropriate patients. These are administered alongside — not as a replacement for — conventional medical treatment, and are always preceded by thorough clinical evaluation.
Ozone therapy delivers a precisely controlled mixture of oxygen and ozone (O₂–O₃) to stimulate the body's own antioxidant defences, improve tissue oxygenation, and modulate immune function.
Medical ozone is a three-atom form of oxygen (O₃) administered via routes including major autohemotherapy (blood ozonation and reinfusion), rectal insufflation, intra-articular injection, and topical application. At therapeutic concentrations of 20–40 μg/mL, it activates superoxide dismutase, catalase, and glutathione peroxidase — the body's core antioxidant enzymes — and stimulates growth factor release to accelerate tissue repair.
The therapy has been studied extensively for pain management, wound healing, and infection control. A 2023 randomised controlled trial in the International Journal of Molecular Sciences found ozone injections comparable to hyaluronic acid for knee osteoarthritis pain relief, while a 2024 multicentre RCT published in PMC demonstrated superior outcomes versus corticosteroids for the same indication.
Chelation therapy uses EDTA (ethylenediaminetetraacetic acid) — a synthetic amino acid — intravenously to bind heavy metal ions in the bloodstream, forming soluble complexes that are safely excreted through the kidneys.
EDTA's hexadentate molecular structure allows it to coordinate-bond with metal ions including lead, mercury, cadmium, arsenic, iron, and zinc. It is the FDA-approved standard of care for lead poisoning, and continues to be studied for cardiovascular applications. The landmark TACT2 trial published in JAMA (2024) evaluated EDTA chelation in post-myocardial infarction patients with diabetes, providing the most rigorous dataset to date on its cardiovascular effects.
Chelation is offered as a component of a wider detoxification and wellness protocol. Prior to treatment, all patients undergo thorough evaluation of renal function, mineral status, and cardiovascular risk. Supplementation of essential minerals is incorporated as standard practice to prevent depletion during treatment.
Intravenous pharmacological-dose ascorbic acid achieves plasma concentrations 100× higher than oral supplementation, enabling mechanisms of action impossible through dietary intake alone — including selective pro-oxidant activity in cancer cells.
At pharmacological doses of 1.5–2.2 g/kg body weight delivered intravenously, ascorbic acid generates hydrogen peroxide selectively within cancer cells — which have elevated labile iron content and low catalase activity — while sparing healthy tissue. It also restores TET enzyme activity, enabling tumour-suppressor gene re-expression through epigenetic pathways, modulates HIF-1α to regulate hypoxia signalling, and enhances T-cell infiltration for immune activation.
A landmark 2024 randomised trial published in Redox Biology found that adding pharmacological ascorbate to gemcitabine and nab-paclitaxel in metastatic pancreatic cancer extended median overall survival from 8.3 to 16 months. Earlier Phase II trials in glioblastoma showed patients surviving approximately 5 months longer with IV vitamin C added to standard treatment.
The therapies described on this page are offered as integrative or complementary options and do not replace conventional medical treatment. All patients are assessed individually — suitability, dosing, and frequency are determined by Prof. Dr. Behera following a full clinical consultation. The peer-reviewed papers linked are provided for educational reference and represent the current state of published evidence; not all described uses are FDA- or CDSCO-approved indications. Please consult directly before commencing any therapy.